Sort   by:  
 Page size 
UnknownPhase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status.
Not available
S-EPMC3804291 | biostudies-literature
UnknownPrediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.
Not available
S-EPMC3221524 | biostudies-literature
UnknownFinal 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial.
Not available
S-EPMC5118045 | biostudies-literature
UnknownClearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6008108 | biostudies-literature
UnknownBosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
Not available
S-EPMC4979199 | biostudies-literature
UnknownCPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.
Not available
S-EPMC6127025 | biostudies-literature
UnknownBosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Not available
S-EPMC5966023 | biostudies-literature
UnknownAdvances in Legume Systematics 14. Classification of Caesalpinioideae. Part 2: Higher-level classification.
Not available
S-EPMC11188994 | biostudies-literature
UnknownThe role of gender in a smoking cessation intervention: a cluster randomized clinical trial.
Not available
S-EPMC3125366 | biostudies-literature
UnknownIdentification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623 | biostudies-literature
Sort   by:  
 Page size